Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  

laurent Lauren2 Laurent3

Cystic Fibrosis




Laurent Pharmaceuticals to participate at the 39th European Cystic Fibrosis Conference, June 9-11, 2016, in Basel, Switzerland”

Laurent Pharmaceuticals to participate at the BIO International Conference, June 6-9, 2016, in San Francisco, CA, USA”




Laurent Pharmaceuticals Receives US$ 3M Development Award From Cystic Fibrosis Foundation Therapeutics

First Canadian Company To Obtain CFFT Therapeutics Development Award

Read more

Laurent Pharmaceuticals featured in Biotech Finances

Read the article